Supraventricular Tachycardia (SVT) is a cardiovascular condition marked by an excessively rapid heartbeat originating above the heart's ventricles. The underlying cause often involves abnormal electrical pathways within the heart, leading to rapid and irregular contractions. Individuals experiencing SVT may encounter fleeting or extended episodes, accompanied by symptoms such as palpitations, dizziness, and breathlessness. Though not typically life-threatening, SVT can substantially disrupt daily life and impact overall well-being. Addressing SVT may involve various approaches, from lifestyle adjustments and pharmaceutical interventions to more invasive procedures like catheter ablation, which aims to restore a normal heart rhythm. Accurate diagnosis and effective management are pivotal in alleviating symptoms and preventing potential complications associated with this prevalent cardiac arrhythmia.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom